<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) is a <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> with an increased risk of developing esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EAC) </plain></SENT>
<SENT sid="1" pm="."><plain>Risk factors for EAC overlap with those for esophageal <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e>), but <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> is surprisingly rare in BE </plain></SENT>
<SENT sid="2" pm="."><plain>We report two cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> directly surrounded by BE </plain></SENT>
<SENT sid="3" pm="."><plain>Both patients had a previous medical history of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, i.e., head and neck <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo>, and were using alcohol and smoking tobacco </plain></SENT>
<SENT sid="4" pm="."><plain>Using immunohistochemistry for p63, CK5, CK7, and CDX2, it was confirmed that these <z:mp ids='MP_0002038'>carcinomas</z:mp> were pure <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo>, and not EACs or esophageal adenosquamous <z:mp ids='MP_0002038'>carcinomas</z:mp> arising from BE </plain></SENT>
<SENT sid="5" pm="."><plain>Using TP53 mutation and loss of heterozygosity analysis, we established that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCCs</z:e> in BE were not <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> of the previously diagnosed head and neck <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> but de novo primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCCs</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>This study shows the strength of molecular analysis as an adjunct to the histopathologic diagnosis for distinguishing between <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> of prior <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, these cases imply that presence of BE is not protective with regards to developing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> in the lower one third of the esophagus </plain></SENT>
<SENT sid="8" pm="."><plain>We suggest that their <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCCs</z:e> arose from islets of squamous epithelium in BE </plain></SENT>
</text></document>